Latest Blogs

Oct 01, 2020
There are established channels to demonstrate your productivity and follow a career path in research and practice. However, if you're passionate about education, you have to think creatively about how to carve out your niche and show your abilities.
Sep 22, 2020
A patient thought prostate cancer surgery meant he would never have to think about cancer again, but he had not been adequately prepared for the long-term impact of his treatment choice.
Sep 22, 2020
My colleague and friend Ginny Mason and I discuss advocacy, "beating the odds," and her perspective 26 years out from an initial diagnosis of inflammatory breast cancer.
Sep 15, 2020
Dr. Deborah Mukherji and Dr. Sally Temraz conducted a survey which examined representation and barriers to women oncologists in the Middle East, and surfaced ideas for improving gender parity in the field.
Subscribe to this column

Guest Commentary

Guest Commentary on ASCOconnection.org provides an interactive platform for leaders in their respective fields to share timely perspectives on oncology topics. If you are an ASCO member interested in contributing a guest post, please contact ascoconnection@asco.org.

Jan 13, 2017
The inaugural ASCO-SITC Clinical Immuno-Oncology Symposium will have three networking sessions, designed to help physicians determine how immunotherapy best fits into their practice, and to explore career development for newcomers to the field of immunotherapy.
Jan 09, 2017
A highly interactive and personal panel discussion and Q&A session will take place in the evening on January 26, before the official opening of the Cancer Survivorship Symposium in San Diego, CA.
Jan 04, 2017
Attend the 2017 Cancer Survivorship Symposium's Presidents Panel to hear Drs. Wanda Filer, Nitin Damle, and Julie M. Vose discuss how professional societies are workingto meet the needs of their members with respect to the care of cancer survivors.
Dec 19, 2016
This new meeting will focus on the clinical application of immunology to cancer care, including immune checkpoint inhibitor therapy and novel combinations, the use of adoptive T-cell therapy and CAR T-cells, predictive and prognostic biomarkers, and more.
Dec 12, 2016
Dr. Smita Bhatia reflects on Dr. Anna T. Meadows' achievements and contributions to the field of survivorship as the 2017 Cancer Survivorship Symposium approaches.
Dec 06, 2016
Survival rates for many types of cancers have continued to improve over the past several decades, contributing to a growing number of long-term cancer survivors. With longer survival, attention to the chronic and long-term adverse treatment effects has become increasingly important.

Pages